111. Congenital myopathy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 10 / Drugs : 17 - (DrugBank : 5) / Drug target gene : 1 - Drug target pathways : 9
Congenital myopathy and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 111 | Congenital myopathy | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.000 |
| 6 | Parkinson disease | 1.000 |
| 299 | Cystic fibrosis | 1.000 |
| 2 | Amyotrophic lateral sclerosis | 1.000 |
| 231 | Alpha-1-antitrypsin deficiency | 1.000 |
| 17 | Multiple system atrophy | 1.000 |
| 46 | Malignant rheumatoid arthritis | 1.000 |
| 49 | Systemic lupus erythematosus | 1.000 |
| 85 | Idiopathic interstitial pneumonia | 1.000 |
| 86 | Pulmonary arterial hypertension | 1.000 |
| 89 | Lymphangioleiomyomatosis | 1.000 |
| 96 | Crohn disease | 1.000 |
| 157 | Sturge-Weber syndrome | 1.000 |
| 158 | Tuberous sclerosis | 1.000 |
| 256 | Muscle glycogenosis | 1.000 |
| 278 | Huge lymphatic malformation with cervicofacial lesion | 1.000 |
| 228 | Bronchiolitis obliterans | 1.000 |
| 5 | Progressive supranuclear palsy | 1.000 |
| 113 | Muscular dystrophy | 1.000 |
| 227 | Osler disease | 1.000 |
| 296 | Biliary atresia | 1.000 |
| 11 | Myasthenia gravis | 1.000 |
| 22 | Moyamoya disease | 1.000 |
| 70 | Spinal stenosis | 1.000 |
| 167 | Marfan syndrome | 1.000 |
| 57 | Idiopathic dilated cardiomyopathy | 1.000 |
| 210 | Single Ventricle | 1.000 |
| 215 | Tetralogy of Fallot | 1.000 |
| 1 | Spinal and bulbar muscular atrophy | 1.000 |
| 118 | Myelomeningocele | 1.000 |
| 169 | Menkes disease | 1.000 |
| 170 | Occipital horn syndrome | 1.000 |
| 3 | Spinal muscular atrophy | 1.000 |
| 12 | Congenital myasthenic syndrome | 1.000 |